Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Quality Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Quality Index of 3.13x as of December 2025. Operating cash flow of CN¥345.31 Million exceeds net income of CN¥110.27 Million, indicating high earnings quality where cash backs reported profits. Explore Jiangsu Hualv Biological Technology Co.L (300970) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300970 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year earnings quality comparison for Jiangsu Hualv Biological Technology Co.Ltd.. For live market cap and the full company financial profile, see market cap of Jiangsu Hualv Biological Technology Co.L.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥345.31 Million | CN¥110.27 Million | ▼ -43.0% |
| 2023 | 5.49x | CN¥166.67 Million | CN¥30.35 Million | ▲ +139.0% |
| 2022 | 2.30x | CN¥179.84 Million | CN¥78.25 Million | ▼ -57.1% |
| 2021 | 5.36x | CN¥83.08 Million | CN¥15.50 Million | ▲ +256.6% |
| 2020 | 1.50x | CN¥199.09 Million | CN¥132.50 Million | ▼ -15.3% |
| 2019 | 1.77x | CN¥213.96 Million | CN¥120.67 Million | — |